AbbVie (ABBV)
$106.70
1.05 (0.99%)
19:56 EST
ABBV Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
169.32B
PE Ratio
26.81
EPS
3.98
Volume (Avg. Vol.)
7.28M
Day's Range
104.07 - 106.99
52-Week Range
62.55 - 113.41
Dividend & Yield
5.20 (4.87%)
ABBV Stock Predictions, Articles, and AbbVie News
- From InvestorPlace
- From the Web
7 Great Dividend Stocks Outside the Energy Sector
By
Alex Sirois
Dividend stocks come in many flavors although investors may associate them primarily with the energy sector. These seven stocks cross industries.
7 Safe Stocks You Can Hold Onto Forever
Euphoric markets are widening the gap between value and growth investments. Let's take a look at safe stocks to buy and hold forever.
9 Safe Stocks for Your 401k
While everybody is chasing the moon and the stars, it might be prudent for you to consider these safe stocks for your 401K.
4 Top Stock Trades for Thursday: AMZN, SPOT, BMY, ABBV
Amazon, Spotify, Bristol-Myers Squibb and AbbVie were our top stock trades for Thursday. Let's look at the charts of these earnings movers.
7 Pharmaceutical Stocks With Compelling Pipelines
Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.
7 Dividend Aristocrats That Will Outlive Us All
These seven Dividend Aristocrats are among the royalty of passive-income generator companies
7 Pharmaceutical Stocks With Exciting Plans for 2021
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.
7 Hot Stocks That Will Keep You Energized With 3%-Plus Yields
These hot stocks combine healthy dividends with lasting brand names, making them some of the smartest picks on the market.
The Top 7 Pharmaceutical Stocks for the Next 10 Years
By
Alex Sirois
Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.
7 Safe Stocks to Buy to Start Off the Year
These safe stocks to buy have a low beta, attractive valuation and healthy dividends. Get in early this year to strengthen your portfolio.
7 Cheap Stocks to Buy in January For a Quick Buck
By
Alex Sirois
2020 has taken the market capitalizations of many strong companies to lows. That means there are some great options for cheap stocks to buy in January.
5 Dividend Stocks Likely to Up Their Yield Soon
Dividend stocks are a special category of financial assets, providing a lot of benefits for investing that make them attractive for the majority of investors.....
7 Medical Marijuana Stocks for a Healthcare Revolution
Medicinal cannabis is no longer speculative. There are truly impactful treatments out there, as well as investment-worthy marijuana stocks.
7 Cheap Stocks to Buy Before the Market Realizes their Worth
Almost everyone likes cheap stocks, because as investors, we don't like to overpay. Some are value traps, while others are treasure chests.
3 Dividend Stocks for Big Total Returns in 2021
These dividend stocks continue to outperform thier competition in yielding higher and consistent returns despite the impact of the pandemic
4 Pharmaceutical Stocks That Aren’t Worth Their Outsized 2020 Gains
By
Joel Baglole
Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors should be weary of in the weeks ahead.
4 Dividend Stocks With Yields Over 5%
Investors have burned of late chasing high-yield dividend stocks. These 4 stocks with yields more than 5% should buck that trend.
7 Stable Blue-Chip Stocks for Today’s Volatile Economy
Blue-chip stocks can generate large returns over time, making for great investments in a turbulent economy. Here are my top 7 picks.
3 Biotech Stocks With Eye-Catching Pipelines
Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist.
AbbVie News: 5 Things for ABBV Investors to Know About Q3
AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company's earnings report for the third quarter of 2020.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold